What else does CBD have to offer?

What else does CBD have to offer?

According to the Journal of Clinical Medicine Research, a single dose of CBD was shown to offer anxiolytic (anti-anxiety) effects, shown to help reduce social anxiety disorders, reduce psychotic disorders, and help to offer help with those who suffer from substance abuse (Larsen, Shahinas, 2020).
CBD has a good safety profile, with a low potential for abuse because of the lack of psychoactive effects (Larsen, Shahinas, 2020). CBD was also shown to have anti-inflammatory benefits, modulates (regulates) our immune response, anti-psychotic, anti-epileptic (seizure), and pain-relieving properties (Larsen, Shahinas, 2020). CBD was shown to reduce the release pro-inflammatory cytokines, which helps explain CBD’s anti-inflammatory properties (Larsen, Shahinas, 2020). CBD was shown to regulate osteoclasts function, which was shown to promote bone health, prevent bone loss, and increase density of bone, making it great for those who suffer from bone density loss and disease (Larsen, Shahinas, 2020).
The Journal of Clinical Medicine Research concluded that CBD was also shown to be effective for schizophrenia, tobacco addiction, and even skin disorders, which I will being going over in further detail later this week (Larsen, Shahinas, 2020).
CBD affects us all differently and there are many factors to take into consideration like route of administration, dosage, and body composition. CBD may help give someone the desired effect they are looking for at 5 mg, while it may take another person to reach those same desired effects at 50 mg.
Therefore, I tell many to play around with the dosage and find what works best for you. If taking one dropper full of CBD oil or 1 gummy does not do it for you, take 2. The best thing about CBD is that it has a great safety profile (Larsen, Shahinas, 2020).

*This information is for educational purposes only and simply sharing of the information pertained to this study. No medical advice or claims are being made.


Larsen, C., & Shahinas, J. (2020). Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials. Journal of clinical medicine research, 12(3), 129–141. https://doi.org/10.14740/jocmr4090

Leave a comment

Your email address will not be published. Required fields are marked *

Related aticles

Custom HTML